Dynavax Technologies
DVAX
#5490
Rank
โ‚น115.80 B
Marketcap
โ‚น986.19
Share price
0.05%
Change (1 day)
-9.68%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น25.63 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is โ‚น25.63 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น21.82 B2.05%
2023-12-31โ‚น21.38 B0.18%
2022-12-31โ‚น21.35 B11.45%
2021-12-31โ‚น19.15 B20.24%
2020-12-31โ‚น15.93 B3.22%
2019-12-31โ‚น15.43 B118.84%
2018-12-31โ‚น7.05 B
2014-12-31โ‚น0.60 B
2012-12-31N/A-100%
2011-12-31โ‚น0.67 B28.35%
2010-12-31โ‚น0.52 B-8.11%
2009-12-31โ‚น0.57 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
โ‚น4.11 B-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น592.71 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น3.721 T 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.243 T 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น2.934 T 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚น2.146 T 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น5.472 T 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.535 T 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น4.909 T 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA